miRNA-195-5p/PSAT1 feedback loop in human triple-negative breast cancer cells

[1] Akram M(2017)Awareness and current knowledge of breast cancer Biol Res 50 33-198

[2] Iqbal M(2014)Serine and glycine metabolism in cancer Trends Biochem Sci 39 191-162

[3] Daniyal M(2021)Potential Role of miRNA in Metastatic Cascade of Triple-Negative Breast Cancer Curr Cancer Drug Targets 21 153-200

[4] Khan AU(2021)miR-195-5p exerts tumor-suppressive functions in human lung cancer cells through targeting TrxR2 Acta Biochim Biophys Sin (Shanghai) 53 189-2522

[5] Amelio I(2020)Overexpression of PSAT1 promotes metastasis of lung adenocarcinoma by suppressing the IRF1-IFNγ axis Oncogene 39 2509-518

[6] Cutruzzolá F(2019)Overexpression of microRNA-195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3β/β-catenin signaling pathway J Transl Med 17 190-141

[7] Antonov A(2020)PSAT1 Upregulation Contributes to Cell Growth and Cisplatin Resistance in Cervical Cancer Cells via Regulating PI3K/AKT Signaling Pathway Ann Clin Lab Sci 50 512-1150

[8] Agostini M(2021)MicroRNA as an Important Target for Anticancer Drug Development Front Pharmacol 12 736323-7070

[9] Melino G(2017)PSAT1 is regulated by ATF4 and enhances cell proliferation via the GSK3β/β-catenin/cyclin D1 signaling pathway in ER-negative breast cancer J Exp Clin Cancer Res 36 179-122

[10] Balkrishna A(2021)The ins and outs of serine and glycine metabolism in cancer Nat Metab 3 131-1730

[1] Akram M(2017)Awareness and current knowledge of breast cancer Biol Res 50 33-198

[2] Iqbal M(2014)Serine and glycine metabolism in cancer Trends Biochem Sci 39 191-162

[3] Daniyal M(2021)Potential Role of miRNA in Metastatic Cascade of Triple-Negative Breast Cancer Curr Cancer Drug Targets 21 153-200

[4] Khan AU(2021)miR-195-5p exerts tumor-suppressive functions in human lung cancer cells through targeting TrxR2 Acta Biochim Biophys Sin (Shanghai) 53 189-2522

[5] Amelio I(2020)Overexpression of PSAT1 promotes metastasis of lung adenocarcinoma by suppressing the IRF1-IFNγ axis Oncogene 39 2509-518

[6] Cutruzzolá F(2019)Overexpression of microRNA-195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3β/β-catenin signaling pathway J Transl Med 17 190-141

[7] Antonov A(2020)PSAT1 Upregulation Contributes to Cell Growth and Cisplatin Resistance in Cervical Cancer Cells via Regulating PI3K/AKT Signaling Pathway Ann Clin Lab Sci 50 512-1150

[8] Agostini M(2021)MicroRNA as an Important Target for Anticancer Drug Development Front Pharmacol 12 736323-7070

[9] Melino G(2017)PSAT1 is regulated by ATF4 and enhances cell proliferation via the GSK3β/β-catenin/cyclin D1 signaling pathway in ER-negative breast cancer J Exp Clin Cancer Res 36 179-122

[10] Balkrishna A(2021)The ins and outs of serine and glycine metabolism in cancer Nat Metab 3 131-1730